ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
Southoz
|
277 |
134K |
27 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
277
|
134K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
Southoz
|
362 |
126K |
7 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
362
|
126K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Southoz
|
102 |
41K |
6 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
102
|
41K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Southoz
|
12K |
3.8M |
18 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
12K
|
3.8M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Institutional Allocation
|
|
Southoz
|
263 |
72K |
17 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
263
|
72K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
Southoz
|
362 |
126K |
10 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
362
|
126K
|
10
|
|
ASX - By Stock
|
WFL |
Re:
Where is Art and his admission that he was wrong?
|
|
Southoz
|
7 |
4.9K |
11 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
7
|
4.9K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Why a trial?
|
|
Southoz
|
107 |
36K |
7 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
107
|
36K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Why a trial?
|
|
Southoz
|
107 |
36K |
26 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
107
|
36K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Southoz
|
1.0K |
412K |
80 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
412K
|
80
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Southoz
|
3.4K |
1.2M |
27 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Reports Q3 Financial Results and Operational Highlights
|
|
Southoz
|
362 |
118K |
8 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
362
|
118K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
FDA
|
|
Southoz
|
122 |
48K |
37 |
10/03/23 |
10/03/23 |
ASX - By Stock
|
122
|
48K
|
37
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Southoz
|
116 |
37K |
15 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
116
|
37K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
|
|
Southoz
|
355 |
99K |
10 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
355
|
99K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
|
|
Southoz
|
355 |
99K |
8 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
355
|
99K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Submits New Information to FDA IND File for SR-aGVHD
|
|
Southoz
|
576 |
209K |
9 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
576
|
209K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Southoz
|
12K |
3.8M |
24 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
12K
|
3.8M
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Ann: US$45 Million Private Placement to Major Shareholders
|
|
Southoz
|
321 |
105K |
4 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
321
|
105K
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
Southoz
|
1.5K |
516K |
8 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
1.5K
|
516K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Chronic Lower Back Pain - the sleeping giant.
|
|
Southoz
|
484 |
150K |
25 |
13/06/22 |
13/06/22 |
ASX - By Stock
|
484
|
150K
|
25
|
|
ASX - By Stock
|
MSB Iron Ore |
Re:
AFR reports that the co to be sued for its promotional announcements.
|
|
Southoz
|
533 |
196K |
22 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
533
|
196K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Deadline for Novartis
|
|
Southoz
|
429 |
132K |
11 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
429
|
132K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
Southoz
|
1.0K |
524K |
14 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
1.0K
|
524K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
Southoz
|
1.0K |
500K |
6 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
1.0K
|
500K
|
6
|
|
Political Debate
|
|
Re:
Christian Porter should back a real inquiry. I never got one
|
|
Southoz
|
153 |
16K |
7 |
07/03/21 |
07/03/21 |
Political Debate
|
153
|
16K
|
7
|
|
Political Debate
|
|
Re:
Christian Porter should back a real inquiry. I never got one
|
|
Southoz
|
153 |
16K |
20 |
07/03/21 |
07/03/21 |
Political Debate
|
153
|
16K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
Southoz
|
508 |
175K |
2 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
508
|
175K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
Southoz
|
508 |
175K |
15 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
508
|
175K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group
|
|
Southoz
|
508 |
175K |
44 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
508
|
175K
|
44
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Report and Accounts (including Appendix 4D)
|
|
Southoz
|
297 |
102K |
4 |
28/02/21 |
28/02/21 |
ASX - By Stock
|
297
|
102K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Report and Accounts (including Appendix 4D)
|
|
Southoz
|
297 |
102K |
3 |
28/02/21 |
28/02/21 |
ASX - By Stock
|
297
|
102K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Report and Accounts (including Appendix 4D)
|
|
Southoz
|
297 |
102K |
5 |
28/02/21 |
28/02/21 |
ASX - By Stock
|
297
|
102K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Southoz
|
272 |
140K |
7 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
272
|
140K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Southoz
|
272 |
140K |
7 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
272
|
140K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB Short Position Reporting
|
|
Southoz
|
255 |
84K |
4 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
255
|
84K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
Southoz
|
1.1K |
321K |
15 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
321K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
Southoz
|
1.1K |
321K |
18 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
321K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
Southoz
|
1.1K |
321K |
4 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
321K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
Southoz
|
1.1K |
321K |
9 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
321K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Pre-Submission package lodged with the US FDA
|
|
Southoz
|
199 |
56K |
6 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
199
|
56K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Pre-Submission package lodged with the US FDA
|
|
Southoz
|
199 |
56K |
5 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
199
|
56K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Pre-Submission package lodged with the US FDA
|
|
Southoz
|
199 |
56K |
7 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
199
|
56K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Pre-Submission package lodged with the US FDA
|
|
Southoz
|
199 |
56K |
15 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
199
|
56K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Pre-Submission package lodged with the US FDA
|
|
Southoz
|
199 |
56K |
8 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
199
|
56K
|
8
|
|
ASX - By Stock
|
WFL |
Re:
Capital Raising 8th February
|
|
Southoz
|
72 |
20K |
3 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
72
|
20K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
Southoz
|
1K |
298K |
7 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
1K
|
298K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MPC-06-ID Phase 3 results countdown
|
|
Southoz
|
273 |
143K |
22 |
26/01/21 |
26/01/21 |
ASX - By Stock
|
273
|
143K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
MPC-06-ID Phase 3 results countdown
|
|
Southoz
|
273 |
143K |
17 |
26/01/21 |
26/01/21 |
ASX - By Stock
|
273
|
143K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
Southoz
|
763 |
329K |
18 |
12/01/21 |
12/01/21 |
ASX - By Stock
|
763
|
329K
|
18
|
|